Either clinico-pathologic or xenograft animal studies showed that WISP1 is the oncogene marker which may be associated with the epithelial-mesenchymal transition (EMT) and inflammatory microenvironment in human prostate cancer development [8,27]. Here, CCN4 is linked to prostate cancer.